TRT Insights

A recent study reveals that medically supervised testosterone replacement therapy (TRT) poses no increased risk of heart attacks, strokes, or prostate cancer in hypogonadal men. This contrasts with previous fears and highlights the growing acceptance of TRT, similar to the evolution of medical marijuana. Despite its benefits, many general practitioners remain unaware of hormone issues, largely due to lingering stigma and lack of education surrounding testosterone.